After an extensive national search, Chandrajit P. Raut, MD, MS, has been named division chief of Surgical Oncology at Brigham Health, effective October 1, 2019.
Dr. Raut,
who is also a professor of surgery at Harvard Medical School and surgery
director of the Center for Sarcoma and Bone Oncology at Dana-Farber Cancer
Institute, is a graduate of Stanford University (BA/BS), University of Oxford
(MSc) and Harvard Medical School (MD). He completed a general surgery residency
at Massachusetts General Hospital followed by a surgical oncology fellowship at
MD Anderson Cancer Center.
Dr. Raut
is a committed clinician who specializes in the multidisciplinary care of patients
with soft tissue sarcoma. He is also a prolific researcher, and currently
has a multi-PI R01 grant to evaluate an innovative drug-eluting film to be
placed in the surgical bed to reduce tumor local recurrence
rates. Additionally, he is co-PI on a multi-institutional phase II
clinical trial evaluating five years of adjuvant imatinib for primary GIST,
co-investigator on an international phase III randomized clinical trial
evaluating the use of preoperative radiation therapy for retroperitoneal
sarcomas, and a member of The Cancer Genome Atlas Sarcoma
(TCGA-SARC) working group of the National
Institutes of Health (NIH)/National Cancer Institute (NCI).
Dr. Raut
serves as section editor for sarcoma in the journals Cancer and Annals
of Surgical Oncology, associate editor for the journal Sarcoma and
an editorial board member for the journal ACS Case Reports in Surgery. He has authored over 200 papers and over 30 book
chapters and also serves as the program director of the
Dana-Farber/Partners Cancer Care Surgical Oncology Fellowship.